1. Arabzade, Amir, Zhao, Yanhua, Varadharajan, Srinidhi, Deneen, Benjamin, Mack, Stephen C. 2021. ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma. In Cancer discovery, 11, 2200-2215. doi:10.1158/2159-8290.CD-20-1066. https://pubmed.ncbi.nlm.nih.gov/33741710/
2. Tauziède-Espariat, Arnault, Nicaise, Yvan, Sievers, Philipp, Uro-Coste, Emmanuelle, Varlet, Pascale. 2024. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas. In Acta neuropathologica communications, 12, 55. doi:10.1186/s40478-023-01695-7. https://pubmed.ncbi.nlm.nih.gov/38581034/
3. Lim, Ka Young, Lee, Kwang Hoon, Phi, Ji Hoon, Choi, Seung Hong, Park, Sung-Hye. 2021. ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor. In Brain pathology (Zurich, Switzerland), 32, e13020. doi:10.1111/bpa.13020. https://pubmed.ncbi.nlm.nih.gov/34506076/
4. Herranz-Pérez, Vicente, Nakatani, Jin, Ishii, Masaki, García-Verdugo, Jose Manuel, Ohata, Shinya. 2022. Ependymoma associated protein Zfta is expressed in immature ependymal cells but is not essential for ependymal development in mice. In Scientific reports, 12, 1493. doi:10.1038/s41598-022-05526-y. https://pubmed.ncbi.nlm.nih.gov/35087169/